BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25220367)

  • 21. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.
    Baldwin PJ; van der Burg SH; Boswell CM; Offringa R; Hickling JK; Dobson J; Roberts JS; Latimer JA; Moseley RP; Coleman N; Stanley MA; Sterling JC
    Clin Cancer Res; 2003 Nov; 9(14):5205-13. PubMed ID: 14614000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case series of young women with spontaneous regression of vulval intraepithelial neoplasia: Demographics and associated HPV genotypes.
    Hilton J; Perkins N; Tabrizi SN; Jones RW
    Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):312-4. PubMed ID: 26940977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses.
    Welters MJ; Kenter GG; de Vos van Steenwijk PJ; Löwik MJ; Berends-van der Meer DM; Essahsah F; Stynenbosch LF; Vloon AP; Ramwadhdoebe TH; Piersma SJ; van der Hulst JM; Valentijn AR; Fathers LM; Drijfhout JW; Franken KL; Oostendorp J; Fleuren GJ; Melief CJ; van der Burg SH
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11895-9. PubMed ID: 20547850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy.
    Abdel-Hady ES; Martin-Hirsch P; Duggan-Keen M; Stern PL; Moore JV; Corbitt G; Kitchener HC; Hampson IN
    Cancer Res; 2001 Jan; 61(1):192-6. PubMed ID: 11196160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fascin and cyclin D1 immunoreactivity in non-neoplastic vulvar squamous epithelium, vulvar intraepithelial neoplasia and invasive squamous carcinoma: correlation with Ki67 and p16 protein expression.
    Stewart CJ; Crook ML
    J Clin Pathol; 2014 Apr; 67(4):319-25. PubMed ID: 24218024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age.
    van de Nieuwenhof HP; Massuger LF; van der Avoort IA; Bekkers RL; Casparie M; Abma W; van Kempen LC; de Hullu JA
    Eur J Cancer; 2009 Mar; 45(5):851-6. PubMed ID: 19117749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
    van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
    Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Immune Checkpoint Inhibitor LAG-3 and Its Ligand GAL-3 in Vulvar Squamous Neoplasia.
    Cocks MM; Mills AM
    Int J Gynecol Pathol; 2022 Mar; 41(2):113-121. PubMed ID: 33782343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.
    Wellenhofer A; Brustmann H
    Arch Pathol Lab Med; 2012 Nov; 136(11):1359-65. PubMed ID: 23106581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer.
    Jach R; Dyduch G; Radon-Pokracka M; Przybylska P; Mika M; Dulinska-Litewka J; Zajac K; Huras H; Streb J; Stangel-Wojcikiewicz K; Dziadek O; Galarowicz B
    Neuro Endocrinol Lett; 2011; 32(4):530-9. PubMed ID: 21876509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination.
    Skapa P; Zamecnik J; Hamsikova E; Salakova M; Smahelova J; Jandova K; Robova H; Rob L; Tachezy R
    Am J Surg Pathol; 2007 Dec; 31(12):1834-43. PubMed ID: 18043037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vulvar intraepithelial neoplasia.
    Preti M; Scurry J; Marchitelli CE; Micheletti L
    Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1051-62. PubMed ID: 25106700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia.
    Hillemanns P; Wang X
    Gynecol Oncol; 2006 Feb; 100(2):276-82. PubMed ID: 16300821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment.
    van Poelgeest MI; van Seters M; van Beurden M; Kwappenberg KM; Heijmans-Antonissen C; Drijfhout JW; Melief CJ; Kenter GG; Helmerhorst TJ; Offringa R; van der Burg SH
    Clin Cancer Res; 2005 Jul; 11(14):5273-80. PubMed ID: 16033846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN.
    Ordi J; Alejo M; Fusté V; Lloveras B; Del Pino M; Alonso I; Torné A
    Am J Surg Pathol; 2009 Nov; 33(11):1659-65. PubMed ID: 19730361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
    Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
    Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Langerhans cell density and high-grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infection.
    Taube JM; Nichols AD; Bornman LS; Bornman DM; Jackson JB
    J Cutan Pathol; 2007 Jul; 34(7):565-70. PubMed ID: 17576336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing T-cell response in low-grade and high-grade vulval intraepithelial neoplasia, study of CD3, CD4 and CD8 expressions.
    Gul N; Ganesan R; Luesley DM
    Gynecol Oncol; 2004 Jul; 94(1):48-53. PubMed ID: 15262118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vulvar intraepithelial neoplasia p53 expression, p53 gene mutation and HPV in recurrent/progressive cases.
    Chulvis do Val IC; Almeida Filho GL; Valiante PM; Gondim C; Takiya CM; Carvalho Mda G
    J Reprod Med; 2004 Nov; 49(11):868-74. PubMed ID: 15603096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.